ClinicalTrials.gov
public full text
Public Domain
Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia
Steroids has shown benefits in COVID19 patients in observational studies. We hypothesized that early use of corticosteroids, low dose, in mild disease, can decrease progression to respiratory failure and death.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis#1045234
- Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease#847972
- Efficacy and Safety of Corticosteroids in COVID-19#980378
- Corticosteroid Therapy in Pulmonary Sequelae of Covid-19#980516
- The heterogeneous treatment effect of adjuvant therapy with corticosteroids in patients with Community-Acquired Pneumonia: a review.#135819
Record · ID 1047919
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive